September 2026
The infectious disease therapeutics market size is calculated at USD 37.67 billion in 2026 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of 3.97%.
September 2026
The infectious disease vaccines market size reached USD 41.60 billion in 2026, with leading infectious disease vaccines market companies including Pfizer, Moderna, Johnson & Johnson (Janssen), GlaxoSmithKline (GSK).
September 2026
The global parkinsons disease therapeutics market size is estimated at USD 7.49 billion in 2026 and is projected to hit around USD 14.28 billion by 2035 with a CAGR of 7.36%.
September 2026
The U.S. point of care infectious disease testing market size is projected to hit around USD 5.27 billion by 2035, growing at a CAGR of 8.98% from 2026 to 2035.
September 2026
The global infectious disease diagnostics market size is expected to reach around USD 71.06 billion by 2035 from USD 37.98 billion in 2026 with a CAGR of 7.22%.
September 2026
The global point-of-care infectious disease diagnostics market size is projected to hit around USD 25.66 billion by 2035, with a CAGR of 15.26% from 2026 to 2035.
September 2026
The infectious disease in-vitro diagnostics market size is valued at USD 28.78 billion in 2026 and is expected to hit around USD 35.68 billion by 2035, growing at a CAGR of 2.42%.
September 2026
The infectious respiratory disease diagnostics market size was USD 60.62 billion in 2026, with leading infectious respiratory disease diagnostics market players including F. Hoffmann - La Roche, Thermo Fisher Scientific, Danaher (Cepheid), Abbott LaboratoriesÂ
September 2026
The global infectious disease molecular diagnostics market size is estimated to hit around USD 63.37 billion by 2034 with a CAGR of 3.25% from 2026 to 2034.
December 2025
The lung disease therapeutics market size was estimated at USD 96.82 billion in 2025 and is expected to hit over USD 173.48 billion by 2035 with a CAGR of 6.01%.
August 2025
The global antibody ELISA kits for tropical infectious disease market size was valued at USD 2.39 billion in 2024 and is expected to hit around USD 4.41 billion by 2034, growing at a CAGR of 6.32%.
September 2026
The infectious disease immunoassay market size stood at USD 3.22 billion in 2026, with major infectious disease immunoassay market companies including Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMérieux SA, Siemens Healthineers AG, Beckman Coulter, Inc.
September 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
September 2026
The global fabry disease treatment market size reached USD 2.65 billion in 2026 and is estimated to hit around USD 5.20 billion by 2035 with a CAGR of 7.82%.
September 2026
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
September 2026
The next-generation RNA therapeutics market is growing with innovations in RNA-based drugs, improving treatments for cancer, genetic diseases, and infectious conditions.
September 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
September 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
September 2026
The global bispecific antibody therapeutics contract manufacturing market size was evaluated at USD 13.4 billion in 2026 and is predicted to hit around USD 218.92 billion by 2035, growing at a CAGR of 36.4%.
September 2026
The global maternal health therapeutics market size was evaluated at USD 5.07 billion in 2026 and is predicted to hit around USD 9.64 billion by 2035, growing at a CAGR of 7.40%.
September 2026
The Europe urinary incontinence therapeutics market was valued at USD 12.14 billion in 2026 and is expected to expand at a CAGR of 3.15% from 2026 to 2035. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The celiac disease treatment market was valued at USD 879.06 million in 2026, with leading companies including Takeda Pharmaceutical Company Limited, Amgen Inc.
September 2026
The anti-inflammatory therapeutics market size was estimated at USD 113.58 billion in 2026 and is expected to hit USD 164.44 billion by 2035, with a CAGR of 4.14%.
September 2026
The global dermatology diagnostic devices and therapeutics market size is projected to hit around USD 31.33 billion by 2035 from USD 17.03 billion in 2026, with a CAGR of 7.02%.
September 2026
The U.S. digital therapeutics market size is exhibited at USD 4.56 billion in 2026 and is predicted to surpass USD 24.09 billion by 2035 with a remarkable CAGR of 20.54%.
September 2026
The global amyloidosis therapeutics market size was valued at USD 3.44 billion in 2026 and is expected to hit around 6.92 billion by 2035, growing at a CAGR of 8.09% from 2026 to 2035.
September 2026
The rare diseases treatment market size was estimated at USD 266.68 billion in 2026and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
September 2026
The mRNA vaccines and therapeutics market size reached USD 130.20Â billion in 2026 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
September 2026
The global chronic disease management market size was estimated at USD 7.51 billion in 2026 and is expected to hit around USD 23.18 billion by 2035, growing at a CAGR of 13.37% from 2026 to 2035.
September 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.51 billion in 2026 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com